Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charlotte Koopal

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Current Opinion in Endocrinology, Diabetes, and Obesity|January 19, 2017
Familial dysbetalipoproteinemia: an underdiagnosed lipid disorderCharlotte Koopal, A David Marais, Frank L J Visseren
BMJ Case Reports|April 6, 2019
Severe hypertriglyceridaemia and pancreatitis in a patient with lipoprotein lipase deficiency based on mutations in lipoprotein lipase (LPL) and apolipoprotein A5 (APOA5) genesCharlotte Koopal, Remy Bemelmans, A David Marais, et al.
Journal of Clinical Lipidology|April 11, 2017
Autosomal dominant familial dysbetalipoproteinemia: A pathophysiological framework and practical approach to diagnosis and therapyCharlotte Koopal, A David Marais, Jan Westerink, et al.
Journal of Clinical Lipidology|September 29, 2016
Tendon xanthomas: Not always familial hypercholesterolemiaCharlotte Koopal, Frank L J Visseren, A David Marais, et al.
Cardiovascular Endocrinology & Metabolism|January 26, 2023
The association between a genetic variant in the <i>SULF2</i> gene, metabolic parameters and vascular disease in patients at high cardiovascular riskBritt E Heidemann, Frank Lj Visseren, Jessica van Setten, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 12, 2023
[An abnormal lipid profile: when to perform additional research for a genetic cause?]Britt E Heidemann, Monique Prinssen, A D Marais, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|August 29, 2025
Applicability of guideline-informing lipid-lowering clinical trials to contemporary real-world patients with atherosclerotic cardiovascular diseasePauline C E Schuitema, Manon C Stam-Slob, Frank L J Visseren, et al.
Journal of Lipid Research|September 21, 2017
Effect of adding bezafibrate to standard lipid-lowering therapy on post-fat load lipid levels in patients with familial dysbetalipoproteinemia. A randomized placebo-controlled crossover trialCharlotte Koopal, A David Marais, Jan Westerink, et al.
Atherosclerosis|August 31, 2015
Association between CETP gene polymorphism, insulin resistance and risk of diabetes mellitus in patients with vascular diseaseCharlotte Koopal, Yolanda van der Graaf, Folkert W Asselbergs, et al.
BMJ Case Reports|November 24, 2022
Clinical heterogeneity in monogenic chylomicronaemiaBritt E Heidemann, Remy H H Bemelmans, A David Marais, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Current Opinion in Endocrinology, Diabetes, and Obesity|January 19, 2017
Familial dysbetalipoproteinemia: an underdiagnosed lipid disorderCharlotte Koopal, A David Marais, Frank L J Visseren
BMJ Case Reports|April 6, 2019
Severe hypertriglyceridaemia and pancreatitis in a patient with lipoprotein lipase deficiency based on mutations in lipoprotein lipase (LPL) and apolipoprotein A5 (APOA5) genesCharlotte Koopal, Remy Bemelmans, A David Marais, et al.
Journal of Clinical Lipidology|April 11, 2017
Autosomal dominant familial dysbetalipoproteinemia: A pathophysiological framework and practical approach to diagnosis and therapyCharlotte Koopal, A David Marais, Jan Westerink, et al.
Journal of Clinical Lipidology|September 29, 2016
Tendon xanthomas: Not always familial hypercholesterolemiaCharlotte Koopal, Frank L J Visseren, A David Marais, et al.
Cardiovascular Endocrinology & Metabolism|January 26, 2023
The association between a genetic variant in the <i>SULF2</i> gene, metabolic parameters and vascular disease in patients at high cardiovascular riskBritt E Heidemann, Frank Lj Visseren, Jessica van Setten, et al.
Nederlands Tijdschrift Voor Geneeskunde|January 12, 2023
[An abnormal lipid profile: when to perform additional research for a genetic cause?]Britt E Heidemann, Monique Prinssen, A D Marais, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|August 29, 2025
Applicability of guideline-informing lipid-lowering clinical trials to contemporary real-world patients with atherosclerotic cardiovascular diseasePauline C E Schuitema, Manon C Stam-Slob, Frank L J Visseren, et al.
Journal of Lipid Research|September 21, 2017
Effect of adding bezafibrate to standard lipid-lowering therapy on post-fat load lipid levels in patients with familial dysbetalipoproteinemia. A randomized placebo-controlled crossover trialCharlotte Koopal, A David Marais, Jan Westerink, et al.
Atherosclerosis|August 31, 2015
Association between CETP gene polymorphism, insulin resistance and risk of diabetes mellitus in patients with vascular diseaseCharlotte Koopal, Yolanda van der Graaf, Folkert W Asselbergs, et al.
BMJ Case Reports|November 24, 2022
Clinical heterogeneity in monogenic chylomicronaemiaBritt E Heidemann, Remy H H Bemelmans, A David Marais, et al.
Pageof 4